Table 1 Characteristics of participants at baseline.
All n = 2362 | Men n = 1186 | Women n = 1176 | P | |
|---|---|---|---|---|
Age, years (SD) | 46 (11) | 45.9 (11) | 46.1 (11) | 0.780 |
SBP, mmHg (SD) | 119 (15) | 122 (15) | 116 (16) | <0.001 |
DBP, mmHg (SD) | 70 (10) | 71 (10) | 68 (10) | <0.001 |
Pulse, bpm (SD) | 63 (8) | 63 (8) | 64 (8) | <0.001 |
BMI kg/m² (SD) | 26.4 (4.3) | 26.7 (3.5) | 26.2 (5) | 0.004 |
Fasting glucose, mmol/l (SD) | 5.3 (0.8) | 5.4 (0.8) | 5.2 (0.7) | <0.001 |
HOMA- IR median (IQR) | 1.5 (0.8–1.8) | 1.6 (0.85–1.94) | 1.34 (0.75–1.63) | <0.001 |
Triglyceride, mmol/l median (IQR) | 1.3 (0.8–1.5) | 1.42 (0.87–1.72) | 1.09 (0.7–1.29) | <0.001 |
LDL cholesterol, mmol/l (SD) | 3.3 (0.9) | 3.4 (0.9) | 3.1 (0.9) | <0.001 |
CRP, mg/l median (IQR) | 2.3 (0.7–2.4) | 2.3 (0.7–2.2) | 2.4 (0.7–2.6) | 0.517 |
New-onset hypertension, n (%) | 121 (5.1) | 68 (5.7) | 53 (4.5) | 0.176 |
New-onset DM, n (%) | 40 (1.7) | 25 (2.1) | 15 (1.3) | 0.118 |
Current smoker, n (%) | 444 (18.8) | 186 (15.7) | 258 (21.9) | <0.001 |
Non-drinker, n (%) | 441 (18.7) | 160 (13.4) | 281 (23.9) | <0.001 |
Statin medication, n (%) | 24 (1) | 14 (12) | 10 (9) | 0.424 |
C2, ml × mmHg−1 × 100 (SD) | 7.85 (3.39) | 8.88 (3.42) | 6.92 (3.09) | <0.001 |